Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Total article views   HTML views PDF downloads Totals
10,331 Dovepress* 9,590+ 1,464 11,054
PubMed Central* 741 304 1,045
Totals 10,331 1,768 12,099
*Since 28 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar